Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity
Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older
Family History of BRCA Mutation Does Not Equal Increased Risk
Daily Vitamin E Supplements Can Lead to Increased PCa Risk
Digital Immunoassay PSA Test May Predict Cancer Recurrence
Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV
Researchers Discover Bacteria Common in Colon Cancer Tissue
Colon Cancer Survival Rates Differ Across Racial Lines
NCI Predicts 42 Percent Increase In Number of Senior Survivors
IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer
NCI CTEP: Approved Trials For The Month of October
FDA Grants Accelerated Approval To Ferriprox for Iron Overload
Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
